Stephen Doster

  • Vanderbilt University

    Functional Insights Into a Major Drug-Resistance Transporter

    As a member of the class of ABC (ATP-binding cassette) transporters, the P-glycoprotein (P-gp) harnesses energy from ATP hydrolysis to power conformational changes that transfer substrates across the cell membrane against a concentration gradient. P-gp transports more than 200 structurally diverse substrates, thereby playing a role in the pharmacokinetics of… Read More

    May. 30, 2019

  • Vanderbilt University

    The dynamic basement

    May. 9, 2019, 10:30 AM by Sanjay Mishra Basement membranes are an ancient form of extracellular matrix composed of complex biological molecules including Collagen IV. As important structural and functional components of tissues, basement membranes are subject to environmental damage, but little is known about how they are repaired. Now, a… Read More

    May. 9, 2019

  • Vanderbilt University

    New trans-institutional program to focus on genetic variations, disease

    May. 9, 2019, 9:03 AM From left, Brinda Selvaraj, Jonathan Sheehan, PhD, Hassane Mchaourab, PhD, and colleagues are part of the new trans-institutional Program in the Molecular Basis of Genetic Diseases. (photo by Steve Green) by Bill Snyder Vanderbilt has established a program to help researchers determine more precisely how… Read More

    May. 9, 2019

  • Vanderbilt University

    Basu & Zhang awarded prestigious Goldwater Scholarships

    May. 8, 2019, 8:53 AM Vanderbilt University sophomore Aakash Basu and junior Eric Zhang have been named Goldwater Scholars. The Goldwater Scholarship is the premier award for undergraduate STEM students who show exceptional promise of becoming the nation’s next generation of research leaders. Basu and Zhang were selected from a… Read More

    May. 8, 2019

  • Vanderbilt University

    Johnson one of six new endowed chairs

    by Kate Derrick May. 3, 2019, 8:15 AM (L to r) Brian T. McCann, Matthew S. Freiberg, Provost Susan R. Wente, Edward Wright-Rios, Ben Ho Park, Owen D. Jones, Carl H. Johnson (Joe Howell/Vanderbilt University) Vanderbilt’s six newest endowed chairs were honored by colleagues,… Read More

    May. 3, 2019

  • Vanderbilt University

    Wilson appointed to ASGCT board of directors

    May. 2, 2019, 8:33 AM by Kelsey Herbers The American Society of Gene and Cell Therapy (ASGCT) has appointed Matthew Wilson, MD, PhD, associate professor of Medicine in Vanderbilt’s Division of Nephrology and Hypertension, to its board of directors. Beginning in May 2019, Wilson will serve a three-year term as… Read More

    May. 3, 2019

  • Vanderbilt University

    A new antibiotic’s mechanism of action

    Apr. 25, 2019, 11:30 AM by Leigh MacMillan The novel antibacterial drug gepotidacin is showing clinical promise for the treatment of skin infections and gonorrhea. Gepotidacin was developed in response to the rising bacterial resistance to fluoroquinolone drugs such as ciprofloxacin. Like fluoroquinolones, gepotidacin acts on the bacterial enzymes gyrase… Read More

    May. 3, 2019

  • Vanderbilt University

    Immune ‘pruning’ in schizophrenia

    Apr. 25, 2019, 11:00 AM by Bill Snyder Arguably the most replicated post-mortem finding in schizophrenia is the loss of dendritic spines from pyramidal cells in the brain’s prefrontal cortex, which is involved in decision-making, attention and moderating social behavior. Pyramidal cells are cortical neurons that communicate with distant neurons. Read More

    May. 3, 2019

  • Vanderbilt University

    Taming the Fear Response

    The Scream, Edvard Munch, PD-US-expired. Disorders arising from trauma and stress, such as post-traumatic stress disorder (PTSD), are a major cause of morbidity and mortality, and they exact a huge economic toll on our society. Hence, a major effort is underway to find new treatments for these diseases. A clue… Read More

    Apr. 30, 2019

  • Vanderbilt University

    Study expands insight on shrinking pancreas in type 1 diabetes

    Apr. 25, 2019, 8:46 AM Investigators using MRI technology to study changes in pancreatic volume to better understand the progression of Type 1 diabetes include, from left, Melissa Hilmes, MD, Daniel Moore, MD, PhD, Alvin Powers, MD, Jon Williams, PhD, and Jack Virostko, PhD. (photo by Jessica Kimber) by Jill… Read More

    Apr. 29, 2019